O

Ohio Sleep Medicine Institute | Dublin, OH

Research site
(Unclaimed)
Location
4975 Bradenton Avenue, Dublin, Ohio, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 29
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 and type 2 narcolepsy from previous parent studies, TA...

Enrolling
Narcolepsy Type 2
Narcolepsy Type 1
Drug: TAK-861

The main aim is to evaluate the effect of TAK-861 on symptoms of narcolepsy, including excessive daytime sleepiness (EDS) as measured by sleep latenc...

Active, not recruiting
Narcolepsy Type 2
Drug: Placebo
Drug: TAK-861

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Enrolling
Sleep Disturbances Associated With Menopause
Drug: Elinzanetant
Other: Placebo
Recently updated

A multicenter study to assess the safety and effectiveness of the Genio dual-sided hypoglossal nerve stimulation system for the treatment of obstruct...

Active, not recruiting
Obstructive Sleep Apnea
Device: Genio™ system

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with mild OSA. The study is a multi-center...

Active, not recruiting
Sleep Apnea, Obstructive
Device: eXciteOSA

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Enrolling
OSA
Drug: Placebo
Drug: AD109

This is a study of the safety, efficacy and pharmacokinetics (PK) of Serdexmethylphenidate (SDX) compared to placebo in subjects with Idiopathic Hype...

Active, not recruiting
Idiopathic Hypersomnia
Other: Placebo
Drug: Serdexmethylphenidate

The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepine...

Active, not recruiting
Myotonic Dystrophy 1
Excessive Daytime Sleepiness
Drug: Placebo oral tablet
Drug: Pitolisant Oral Tablet

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems